Juno publishes a certificate of analysis for every batch that leaves our facility. HPLC purity, mass spec identity, endotoxin levels, and storage specs — downloadable as PDF.
HPLC purity — reverse-phase, ≥98% minimum. Full chromatogram on file.
Mass spec identity — molecular weight confirmation against expected sequence.
Endotoxin (LAL) — <0.1 EU/mg, kinetic chromogenic method.
Sterility — USP <71> protocol, 14-day culture.
| Product | Lot | Purity (HPLC) | MW Confirmed | Test Date | COA |
|---|---|---|---|---|---|
| Core BPC-157 · 10 mg |
2604-C | 99.3% | ✓ MS | 2026-03-14 | Download PDF → |
| Tether TB-500 · 5 mg |
2604-T | 98.9% | ✓ MS | 2026-03-12 | Download PDF → |
| Nocturne CJC/Ipa · 10 mg |
2604-A | 98.4% | ✓ MS | 2026-03-08 | Download PDF → |
| Ember MOTS-c · 10 mg |
2603-E | 98.7% | ✓ MS | 2026-03-02 | Download PDF → |
| Renew GHK-Cu · 50 mg |
2604-R | 99.1% | ✓ MS | 2026-03-18 | Download PDF → |
| Halo PT-141 · 10 mg |
2604-H | 98.8% | ✓ MS | 2026-03-20 | Download PDF → |
| Tide Selank · 10 mg |
2604-S | 99.0% | ✓ MS | 2026-03-22 | Download PDF → |
| Pulse Semax · 10 mg |
2604-P | 98.6% | ✓ MS | 2026-03-24 | Download PDF → |
A plain-language review of the GH and IGF-1 literature specific to women in the perimenopausal and postmenopausal window.
An honest look at what has and has not been demonstrated in tendon, joint, and gut lining research — including the gaps in human trials.
Thirty years of GHK-Cu research, filtered through the lens of the 30% collagen loss that happens in the first five years after menopause.
Mitochondrial peptides are among the most interesting frontiers in longevity research, and the ovary-specific literature is particularly compelling.